Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.

J Neurogenet

Geriatrics Research, Education, and Clinical Center, Ann Arbor VAHS, Ann Arbor, Michigan 48109-2200, USA.

Published: June 2009

SPG3A/atlastin-1 gene mutations cause an autosomal dominant form of hereditary spastic paraplegia (SPG3A-HSP). We used positron emission tomography with [(11)C]DTBZ to assess nigrostriatal dopaminergic integrity in two unrelated adults with SPG3A-HSP due to the common SPG3A/atlastin-1 mutation, R239C. Nigrostriatal dopaminergic terminal density was normal. A difference from the human pattern of neurodegeneration is a critical limitation of this Drosophila model of SPG3A-HSP. This major difference between human SPG3A/atlastin-1 mutations and the Drosophila atl(l) phenotype has several possible explanations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743137PMC
http://dx.doi.org/10.1080/01677060802337307DOI Listing

Publication Analysis

Top Keywords

hereditary spastic
8
spastic paraplegia
8
nigrostriatal dopaminergic
8
difference human
8
normal dopaminergic
4
dopaminergic nigrostriatal
4
nigrostriatal innervation
4
innervation spg3a
4
spg3a hereditary
4
paraplegia spg3a/atlastin-1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!